Markets declined due to global and domestic pressures, with the Nifty testing support at 25040. Glenmark Pharma partnered with Hengrui Phar...

Glenmark Pharmaceuticals has partnered with Hengrui Pharma, securing exclusive rights to develop and commercialize Trastuzumab Rezetecan gl...

Driven by the success of Wegovy and Mounjaro, numerous pharma companies are developing anti-obesity drugs, with over 170 in various stages....

Merck is close to buying Verona Pharma, a biotech firm specializing in lung diseases. The deal is valued at around $10 billion. Merck aims ...

FWD Group, a pan-Asian insurer founded by Richard Li, is seeking to raise US$512 million in a Hong Kong IPO. The deal values the company at...

DeepSeek is transforming China's AI landscape, powering personal computers, robots, and electric vehicles despite US sanctions. The Hangzho...

Cipla shares rose by 2.4% to Rs 1,483.40 on Tuesday after Kotak Institutional Equities upgraded the stock from "add" to "buy," with a targe...

GSK will pay $1 billion upfront and up to $400 million in certain success-based regulatory milestone payments. It will also make milestone ...

The blue-chip CSI300 index gained 0.2 per cent at 5,155.97, while the Shanghai Composite Index was unchanged at 3,566.65.

China's blue-chip CSI300 index was up 0.92 per cent, with its financial sector sub-index higher by 0.72 per cent, the consumer staples sect...

Shanghai Composite Index ended up 0.7 percent at 3,114.21.

To Yang, China has become a prime market for investing in quality consumer-focused companies.